{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:47:24Z","timestamp":1777312044757,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010230","name":"Qinghai University","doi-asserted-by":"publisher","award":["2023-QYY-1"],"award-info":[{"award-number":["2023-QYY-1"]}],"id":[{"id":"10.13039\/501100010230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrc.2026.153710","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:19:23Z","timestamp":1775603963000},"page":"153710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Role of the NF-\u03baB signaling pathway in vascular endothelial cell injury associated with metabolic dysfunction-associated steatotic liver disease under hypoxia"],"prefix":"10.1016","volume":"817","author":[{"given":"Jingxuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5041-1118","authenticated-orcid":false,"given":"Guodan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153710_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/metabo14010012","article-title":"Lipid metabolism in metabolic-associated steatotic liver disease (MASLD)","volume":"14","author":"Syed-Abdul","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.bbrc.2026.153710_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3350\/cmh.2024.0109","article-title":"Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"30","author":"Crane","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153710_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2026.153710_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153710_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach","volume":"28","author":"Le","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153710_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2026.153710_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrc.2026.153710_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155642","article-title":"Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States","volume":"146","author":"Golabi","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2026.153710_bib9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s12072-021-10182-x","article-title":"Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait","volume":"15","author":"Sanai","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbrc.2026.153710_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/ceh.2018.73155","article-title":"The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases","volume":"4","author":"W\u00f3jcik-Cichy","year":"2018","journal-title":"Clin. Exp. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153710_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/jcm10030467","article-title":"NAFLD and cardiovascular diseases: epidemiological, mechanistic and therapeutic considerations","volume":"10","author":"Niederseer","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2026.153710_bib12","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1042\/CS20200446","article-title":"Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis","volume":"134","author":"Zhang","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbrc.2026.153710_bib13","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jhep.2023.08.023","article-title":"Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated inhibition of cellular cholesterol efflux","volume":"79","author":"Chen","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153710_bib14","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153710_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12072-023-10543-8","article-title":"An international multidisciplinary consensus statement on MAFLD and the risk of CVD","volume":"17","author":"Zhou","year":"2023","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbrc.2026.153710_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jhep.2011.04.022","article-title":"Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese","volume":"56","author":"Aron-Wisnewsky","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153710_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1344971","article-title":"Hypoxia-inducible factor-2\u03b1 promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells","volume":"15","author":"Yan","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.153710_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq5226","article-title":"NF-\u03baB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment","volume":"10","author":"de la Calle-Fabregat","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2026.153710_bib19","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000988","article-title":"Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American heart association","volume":"144","author":"Yeghiazarians","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.153710_bib20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41419-020-02943-7","article-title":"Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1\/AKT pathway","volume":"11","author":"Dou","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153710_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.153710_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8798","article-title":"Targeting acid ceramidase inhibits YAP\/TAZ signaling to reduce fibrosis in mice","volume":"12","author":"Alsamman","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.153710_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jhep.2023.03.041","article-title":"HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia","volume":"79","author":"Povero","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153710_bib24","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153710_bib25","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.bbrc.2026.153710_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbrc.2021.01.002","article-title":"Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-\u03baB signalling pathway","volume":"540","author":"Cai","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153710_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver Fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153710_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/obr.12034","article-title":"Hypoxia, energy balance and obesity: from pathophysiological mechanisms to new treatment strategies","volume":"14","author":"Kayser","year":"2013","journal-title":"Obes. Rev."},{"key":"10.1016\/j.bbrc.2026.153710_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fphys.2019.00430","article-title":"Body composition and body weight changes at different altitude levels: a systematic review and meta-analysis","volume":"10","author":"D\u00fcnnwald","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2026.153710_bib30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1194\/jlr.M090969","article-title":"CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway","volume":"60","author":"Li","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2026.153710_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13578-025-01411-z","article-title":"Post-translational modifications in the pathophysiological process of metabolic dysfunction-associated steatotic liver disease","volume":"15","author":"Min","year":"2025","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbrc.2026.153710_bib32","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/antiox12111910","article-title":"Chronic intermittent hypoxia-induced dysmetabolism is associated with hepatic oxidative stress, mitochondrial dysfunction and inflammation","volume":"12","author":"Fernandes","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2026.153710_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1039241","article-title":"ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153710_bib34","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.7150\/ijms.99359","article-title":"Mitochondrial stress as a central player in the pathogenesis of hypoxia-related myocardial dysfunction: new insights","volume":"21","author":"Guo","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbrc.2026.153710_bib35","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1038\/s41467-024-51995-2","article-title":"Hypoxia induces ROS-resistant memory upon reoxygenation in vivo promoting metastasis in part via MUC1-C","volume":"15","author":"Godet","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153710_bib36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.7150\/ijbs.63219","article-title":"The advanced glycation end-products (AGEs)\/ROS\/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration","volume":"18","author":"Wan","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.153710_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108888","article-title":"Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction","volume":"100","author":"Li","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbrc.2026.153710_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153710_bib39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153710_bib40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12944-015-0141-z","article-title":"Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis","volume":"14","author":"Xu","year":"2015","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbrc.2026.153710_bib41","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.3390\/ijms221910701","article-title":"Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF-\u03baB activation: a review of the molecular mechanisms","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153710_bib42","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.bbrc.2026.153710_bib43","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.3390\/molecules27113426","article-title":"Action sites and clinical application of HIF-1\u03b1 inhibitors","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153710_bib44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1165\/rcmb.2020-0492OC","article-title":"Hepatocyte HIF-1 and intermittent hypoxia independently impact liver fibrosis in murine nonalcoholic fatty liver disease","volume":"65","author":"Mesarwi","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.153710_bib45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41366-023-01443-w","article-title":"The role of adipose tissue and subsequent liver tissue hypoxia in obesity and early stage metabolic dysfunction associated steatotic liver disease","volume":"48","author":"Van Eyck","year":"2024","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbrc.2026.153710_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1196033","article-title":"Monocyte-endothelial cell interactions in vascular and tissue remodeling","volume":"14","author":"Medrano-Bosch","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153710_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151744","article-title":"Low-frequency, mild-gradient chronic intermittent hypoxia still induces liver fibrogenesis in mice on a high-fat diet","volume":"761","author":"Kudo","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153710_bib48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2019.11.001","article-title":"Linking regulation of nitric oxide to endothelin-1: the Yin and Yang of vascular tone in the atherosclerotic plaque","volume":"292","author":"Gupta","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.153710_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.atherosclerosis.2019.09.020","article-title":"Endothelin-1 increases expression and activity of arginase 2 via ETB receptors and is co-expressed with arginase 2 in human atherosclerotic plaques","volume":"292","author":"Rafnsson","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.153710_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103675","article-title":"Hypobaric hypoxia-driven energy metabolism disturbance facilitates vascular endothelial dysfunction","volume":"84","author":"Zhang","year":"2025","journal-title":"Redox Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:10:18Z","timestamp":1777309818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26004742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"alternative-id":["S0006291X26004742"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153710","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the NF-\u03baB signaling pathway in vascular endothelial cell injury associated with metabolic dysfunction-associated steatotic liver disease under hypoxia","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153710"}}